E2609
Drug timelines are a Plus or Pro feature.
11 regulatory and trial events tracked for E2609, covering 2013-05-22 to 2021-03-05. Get the full timeline:
Most recent: Clinical Trial Update: Dose-Finding Study To Evaluate Safety, Tolerability, and Efficacy of E2609 in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (Prodromal Alzheimer's Disease) and Mild to Moderate Dementia Due to Alzheimer's Disease [Phase 2]